Dexmedtomidine hydroc

The Defense Logistics Agency Troop Support Medical seeks quotes for one VI of dexmedtomidine hydrochloride injection, NSN 6509-01-569-7067, under Request for Quotations SPE2DP27T0298, with quotes due November 18, 2026. The solicitation carries a No Set-Aside Used designation, is issued by DLA office SPE2DP as a Fast Auto Evaluation solicitation, and requires quote submission through DIBBS.

Delivery is required within 20 days to Fort Bragg, North Carolina, on FOB Destination terms with inspection and acceptance at destination. PSC 6509 classifies the item as Drugs and Biologicals, Veterinary Use, and the attached government file describes a 10mL multi-dose vial sedative and analgesic for dogs and cats. The item is FDA-regulated, and the apparently successful offeror must submit product confirmation referrals to a product specialist in EBS before award. Required shelf life is 24 months, non-extendable, with DLA packaging requirements and Medical Marking Standard No. 1 applying. The solicitation applies Buy American Act and Balance of Payments Program requirements to quotes above the micro-purchase threshold and incorporates the DLA Master Solicitation for Automated Simplified Acquisitions, Revision 106, dated November 3, 2026. Quotes for micro-purchase items may be awarded before the return date. Clauses cover hazardous material identification, safety data sheets, sea transportation, covered defense telecommunications prohibitions, small business representations, and safeguarding covered defense information. Payment is through Wide Area Workflow.

Procurement history cited in the attached government file shows repeated awards for this NSN from February through October 2026 to CAGE 4PG41 (Covetrus North America, LLC) at unit costs of $91.79 to $91.80.